Stock Information

Symbol

NASDAQ: SCMP

Price

Change

Volume

52 week Low/High

Day Low/High

Company Overview

Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products - AMITIZA, its lead product, and RESCULA - and a pipeline of product candidates in clinical development. A global company, Sucampo is headquartered in Rockville, Maryland, and has operations in Japan, Switzerland and the U.K.

Contact Information

Investor Relations
Silvia Taylor
Senior Vice President, Investor Relations and Corporate Affairs
T: 240-223-3718
investor@sucampo.com

Transfer Agent
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
T: 718-921-8200
info@amstock.com